Drug intelligence / Profile preview

Klosterfrau Allergin Globuli

Development stage: Unknown
Lead developer: MCM Klosterfrau
Administration: Oral

Overview

Klosterfrau Allergin Globuli is a homeopathic medicinal product developed by MCM Klosterfrau Vertriebs GmbH for the treatment of hay fever and pollen-induced allergic rhinitis. The active ingredient is a D2 dilution of *Adhatoda vasica* (Indian lungwort), which contains the alkaloid vasicin. This component is traditionally thought to dilate bronchial branches and reduce mucus production. The product is formulated as oral sucrose pellets (globuli) and is suitable for children from 6 years of age. It has been evaluated in Phase 3 clinical trials to assess its efficacy and tolerability in pediatric populations suffering from seasonal allergic symptoms such as itchy eyes and sneezing.

Brand names: Klosterfrau Allergin Globuliallergin
Other names: Adhatoda vasica Dil. D2Adhatoda vasica D2

Beyond the preview

Go deeper on Klosterfrau Allergin Globuli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klosterfrau Allergin Globuli.

Explore the full profile